SLC2A1 and hepatocellular carcinoma: Multiple studies and reviews have reported the consistent upregulation of glucose transporters (GLUT1/2) and glycolytic enzymes (HK2, GAPDH, PKM2, LDHA) across non-Cs HCC types [55].